Published in Acta Psychiatr Scand Suppl on January 01, 1989
Is dose escalation of antidepressants a rational strategy after a medium-dose treatment has failed? A systematic review. Eur Arch Psychiatry Clin Neurosci (2005) 1.11
Paroxetine-mediated GRK2 inhibition reverses cardiac dysfunction and remodeling after myocardial infarction. Sci Transl Med (2015) 1.06
Metabolism and pharmacokinetics of selective serotonin reuptake inhibitors. Cell Mol Neurobiol (1999) 0.96
Serotonin transporter genotype interacts with paroxetine plasma levels to influence depression treatment response in geriatric patients. J Psychiatry Neurosci (2008) 0.95
The AGNP-TDM Expert Group Consensus Guidelines: focus on therapeutic monitoring of antidepressants. Dialogues Clin Neurosci (2005) 0.84
The impact of the CYP2D6-polymorphism on dose recommendations for current antidepressants. Eur Arch Psychiatry Clin Neurosci (2006) 0.82
Possible impact of the CYP2D6*10 polymorphism on the nonlinear pharmacokinetic parameter estimates of paroxetine in Japanese patients with major depressive disorders. Pharmgenomics Pers Med (2014) 0.81
Quantitative cross-species extrapolation between humans and fish: the case of the anti-depressant fluoxetine. PLoS One (2014) 0.79
The influence of 5-HTTLPR genotype on the association between the plasma concentration and therapeutic effect of paroxetine in patients with major depressive disorder. PLoS One (2014) 0.78
"There is no dose-response relationship in psychopharmacotherapy" vs "pharmacotherapy in psychiatry is based on ligand-receptor interaction": a unifying hypothesis and the need for plasma concentration based clinical trials. Psychopharmacology (Berl) (2011) 0.76
Exposure-outcome analysis in depressed patients treated with paroxetine using population pharmacokinetics. Drug Des Devel Ther (2015) 0.75
The effect of age on plasma levels of propranolol and practolol in man. Br J Clin Pharmacol (1975) 2.28
Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group. Arch Gen Psychiatry (1997) 2.26
Cardiac and pulmonary effects of acebutolol. Lancet (1975) 2.12
Studies of cardioselectivity and partial agonist activity in beta-adrenoceptor blockade comparing effects on heart rate and peak expiratory flow rate during exercise. Br J Clin Pharmacol (1978) 2.07
New approach to assessment of cardioselectivity of beta-blocking drugs. Br Med J (1974) 2.06
An investigation into the cardiac and pulmonary beta-adrenoceptor blocking activity of ICI 66,082 in man. Br J Clin Pharmacol (1975) 2.05
Disposition of oral metronidazole in hepatic cirrhosis and in hepatosplenic schistosomiasis. Gut (1982) 1.59
Absorption of propranolol and practolol in Coeliac disease. Gut (1976) 1.55
A rapid and specific semi-micro method involving high-pressure liquid chromatography for the assay of metronidazole in plasma, saliva, serum, urine and whole blood. Br J Clin Pharmacol (1980) 1.38
A pharmacokinetic study of granisetron (BRL 43694A), a selective 5-HT3 receptor antagonist: correlation with anti-emetic response. Cancer Chemother Pharmacol (1989) 1.36
Acebutolol: ten years of experience. Am Heart J (1985) 1.31
A review of the metabolism and pharmacokinetics of paroxetine in man. Acta Psychiatr Scand Suppl (1989) 1.26
Proceedings: The influence of urine pH on the renal excretion of practolol and propranolol. Br J Pharmacol (1973) 1.20
A comparison of quetiapine and chlorpromazine in the treatment of schizophrenia. Acta Psychiatr Scand (1997) 1.17
An investigation of the relationship between beta-adrenoceptor blockade and plasma practolol concentration in man. Eur J Clin Pharmacol (1974) 1.14
Observations on the metabolism of allyl compounds in the rat. Biochem J (1969) 1.09
Pharmacokinetics of metronidazole and its principal metabolites and their activity against Gardnerella vaginalis. Br J Vener Dis (1982) 1.06
The pharmacokinetics of acebutolol in man, following the oral administration of acebutolol HCl as a single dose (400 mg), and during and after repeated oral dosing (400 mg, b.d.). Biopharm Drug Dispos (1981) 0.95
Pharmacokinetics and anti-emetic efficacy of BRL43694, a new selective 5HT-3 antagonist. Br J Cancer (1988) 0.94
A multicentre, double-blind, randomized comparison of quetiapine (ICI 204,636, 'Seroquel') and haloperidol in schizophrenia. Psychol Med (2000) 0.94
Observations on the pharmacokinetics of acebutolol. Clin Pharmacol Ther (1976) 0.93
Observations on the clinical pharmacology and plasma concentrations of diacetolol, the major human metabolite of acebutolol. Br J Clin Pharmacol (1981) 0.92
A study of practolol elimination in all grades of chronic renal failure. Int J Clin Pharmacol Biopharm (1975) 0.90
A study of the influence of pH on the buccal absorption and renal excretion of procainamide. Eur J Clin Pharmacol (1974) 0.89
Lack of correlation between acetylator status and the production of the acetyl metabolite of acebutolol in man. Br J Clin Pharmacol (1978) 0.89
Effects of granisetron and lorazepam, alone and in combination, on psychometric performance. Br J Clin Pharmacol (1991) 0.89
Biosynthesis of mercapturic acids from allyl alcohol, allyl esters and acrolein. Biochem J (1973) 0.88
A high-pressure liquid chromatographic methods for the assay of ketoprofen in plasma and urine, and its application to determining the urinary excretion of free and conjugated ketoprofen following oral administrations of Orudis to man. Br J Clin Pharmacol (1981) 0.88
Variable pharmacokinetics of mexiletine. Postgrad Med J (1977) 0.87
Preliminary observations on the excretion of acebutolol and its acetyl metabolite in the urine and faeces of man. J Pharm Pharmacol (1981) 0.87
Linear pharmacokinetic behavior of ropinirole during multiple dosing in patients with Parkinson's disease. J Clin Pharmacol (2000) 0.86
A comparison of the absorption of effervescent preparations of paracetamol and penicillin V (phenoxymethylpenicillin) with solid dose forms of these drugs. J Clin Pharmacol (1974) 0.86
Plasma prolactin in schizophrenia subjects treated with Seroquel (ICI 204,636). Psychopharmacol Bull (1996) 0.86
Paroxetine does not affect the cardiac safety and pharmacokinetics of terfenadine in healthy adult men. J Clin Psychopharmacol (1997) 0.84
A simple and sensitive H.P.L.C. method for the assay of prochlorperazine in plasma. Br J Clin Pharmacol (1982) 0.84
Effects of granisetron and haloperidol, alone and in combination, on psychometric performance and the EEG. Br J Clin Pharmacol (1992) 0.82
Intravenous metronidazole in the newborn. Arch Dis Child (1983) 0.82
A comparison of plasma and synovial fluid profiles of standard and controlled-release formulations of ketoprofen in patients with rheumatoid arthritis. Curr Med Res Opin (1986) 0.82
Acebutolol and coronary artery surgery. Plasma levels following oral pre-operative treatment. Anaesthesia (1982) 0.81
The metabolic formation of mercapturic acids from allyl halides. Xenobiotica (1972) 0.81
A comparison of bd and tid dose regimens of quetiapine (Seroquel) in the treatment of schizophrenia. Psychopharmacology (Berl) (1998) 0.80
The biliary excretion of acebutolol in man. J Pharm Pharmacol (1976) 0.80
The pharmacokinetics of paroxetine in renal impairment. Acta Psychiatr Scand Suppl (1989) 0.79
Preliminary observations on the elimination of acebutolol in severe chronic renal failure. Br J Clin Pharmacol (1976) 0.79
Serum, saliva, and sputum levels of metronidazole in acute exacerbations of chronic bronchitis. Thorax (1981) 0.79
The influence of pH on the buccal absorption and plasma and renal elimination of acebutolol. Br J Clin Pharmacol (1976) 0.79
Determination of paroxetine in human plasma, using high-performance liquid chromatography with fluorescence detection. J Chromatogr (1987) 0.79
An investigation of "absolute plasma level effect relationships" and "absolute cardioselectivity" with respect to beta-adrenoceptor blockade. Eur J Clin Pharmacol (1977) 0.79
Timing of prophylactic antibiotics in abdominal surgery: trial of a pre-operative versus an intra-operative first dose. Br J Surg (1989) 0.78
Changes in plasma concentrations of acebutolol, propranolol and indomethacin during physical exercise. Life Sci (1981) 0.77
Pharmacokinetics and tolerability of ascending intravenous doses of granisetron, a novel 5-HT3 antagonist, in healthy human subjects. Eur J Clin Pharmacol (1994) 0.77
ICI 204,636: a new atypical antipsychotic drug. Br J Psychiatry Suppl (1996) 0.77
Procainamide absorption studies to test the feasibility of using a sustained-release preparation. Br J Clin Pharmacol (1975) 0.76
The renal excretion of mexiletine (Kö 1173) under controlled conditions of urine pH. Br J Clin Pharmacol (1974) 0.76
Preliminary study of the disposition in man of acebutolol and its metabolite, diacetolol, using a new stereoselective hplc method. J Pharm Pharmacol (1984) 0.76
The influence of urine pH on the renal excretion of ICI 66082 in man. Br J Clin Pharmacol (1974) 0.75
Enterohepatic circulation of practolol in man. Br J Clin Pharmacol (1974) 0.75
The synthesis of mercapturic acids from allyl compounds in the rat. Biochem J (1972) 0.75
The penetration of metronidazole into synovial fluid. Postgrad Med J (1982) 0.75
A simple spectrophotofluorometric method for the measurement of I.C.I. 66082 in plasma and urine. Br J Clin Pharmacol (1974) 0.75
Mercapturic acid formation from Allyl compounds in the rat. Biochem J (1970) 0.75
The different effects of sodium bicarbonate and aluminium hydroxide on the absorption of indomethacin in man. Postgrad Med J (1977) 0.75
New drugs: beta blockers and sympathomimetics. Br Med J (Clin Res Ed) (1983) 0.75
Propranolol absorption in Crohn's disease and coeliac disease. Br Med J (1977) 0.75
The influence of urinary pH on the elimination of mexiletine. Br J Clin Pharmacol (1974) 0.75
The influence of pH on the buccal absorption and renal excretion of disopyramide in man. Br J Clin Pharmacol (1976) 0.75
Beta-adrenoceptor antagonists and respiratory function. Br J Clin Pharmacol (1978) 0.75
Concentration of metronidazole and its major metabolites in continuous ambulatory peritoneal dialysate. J Antimicrob Chemother (1983) 0.75
The pharmacokinetics of paroxetine in the elderly. Acta Psychiatr Scand Suppl (1989) 0.75
Pharmacokinetics of salicylate and indomethacin in coeliac disease. Eur J Clin Pharmacol (1977) 0.75
Metronidazole metabolism following oral benzoylmetronidazole suspension in children with giardiasis. J Antimicrob Chemother (1986) 0.75
The synthesis of mercapturic acids from diethyl sulphate and di-n-propyl sulphate in the rat. Xenobiotica (1974) 0.75
The penetration of trimethoprim and sulphamethoxazole into synovial fluid. J Antimicrob Chemother (1983) 0.75
Absorption of paroxetine under various dietary conditions and following antacid intake. Acta Psychiatr Scand Suppl (1989) 0.75
Effect of meal size and composition on the bioavailability of ketoprofen (Oruvail). Xenobiotica (1987) 0.75
Simple and sensitive method for monitoring zopiclone in plasma by high-performance liquid chromatography with fluorescence detection. Analyst (1985) 0.75